Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Long-Term Investments: 2009-2018

Historic Long-Term Investments for Pediatrix Medical (MD) over the last 10 years, with Q4 2018 value amounting to $69.7 million.

  • Pediatrix Medical's Long-Term Investments fell 1361.27% to $69.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $69.7 million, marking a year-over-year decrease of 1361.27%. This contributed to the annual value of $69.7 million for FY2018, which is 1361.27% down from last year.
  • According to the latest figures from Q4 2018, Pediatrix Medical's Long-Term Investments is $69.7 million, which was down 1361.27% from $81.2 million recorded in Q3 2018.
  • In the past 5 years, Pediatrix Medical's Long-Term Investments ranged from a high of $90.3 million in Q1 2018 and a low of $56.5 million during Q1 2014
  • Its 5-year average for Long-Term Investments is $72.9 million, with a median of $72.1 million in 2016.
  • Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 3353.47% in 2016, then plummeted by 1361.27% in 2018.
  • Over the past 5 years, Pediatrix Medical's Long-Term Investments (Quarter) stood at $64.1 million in 2014, then decreased by 1.24% to $63.3 million in 2015, then rose by 24.79% to $79.0 million in 2016, then grew by 2.16% to $80.7 million in 2017, then fell by 13.61% to $69.7 million in 2018.
  • Its last three reported values are $69.7 million in Q4 2018, $81.2 million for Q3 2018, and $90.2 million during Q2 2018.